1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Dabrafenib
        1.2.3 Trametinib
        1.2.4 Lifirafenib
        1.2.5 Other
    1.3 Market by Application
        1.3.1 Global Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Squamous Cell Carcinoma of NSCLC
        1.3.3 Adenocarcinoma of NSCLC
        1.3.4 Large Cell Carcinoma of NSCLC
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Targeted Drug BRAF Inhibitors for NSCLC Market Perspective (2017-2028)
    2.2 Targeted Drug BRAF Inhibitors for NSCLC Growth Trends by Region
        2.2.1 Targeted Drug BRAF Inhibitors for NSCLC Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Targeted Drug BRAF Inhibitors for NSCLC Historic Market Size by Region (2017-2022)
        2.2.3 Targeted Drug BRAF Inhibitors for NSCLC Forecasted Market Size by Region (2023-2028)
    2.3 Targeted Drug BRAF Inhibitors for NSCLC Market Dynamics
        2.3.1 Targeted Drug BRAF Inhibitors for NSCLC Industry Trends
        2.3.2 Targeted Drug BRAF Inhibitors for NSCLC Market Drivers
        2.3.3 Targeted Drug BRAF Inhibitors for NSCLC Market Challenges
        2.3.4 Targeted Drug BRAF Inhibitors for NSCLC Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Targeted Drug BRAF Inhibitors for NSCLC Players by Revenue
        3.1.1 Global Top Targeted Drug BRAF Inhibitors for NSCLC Players by Revenue (2017-2022)
        3.1.2 Global Targeted Drug BRAF Inhibitors for NSCLC Revenue Market Share by Players (2017-2022)
    3.2 Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Targeted Drug BRAF Inhibitors for NSCLC Revenue
    3.4 Global Targeted Drug BRAF Inhibitors for NSCLC Market Concentration Ratio
        3.4.1 Global Targeted Drug BRAF Inhibitors for NSCLC Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Targeted Drug BRAF Inhibitors for NSCLC Revenue in 2021
    3.5 Targeted Drug BRAF Inhibitors for NSCLC Key Players Head office and Area Served
    3.6 Key Players Targeted Drug BRAF Inhibitors for NSCLC Product Solution and Service
    3.7 Date of Enter into Targeted Drug BRAF Inhibitors for NSCLC Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Drug BRAF Inhibitors for NSCLC Breakdown Data by Type
    4.1 Global Targeted Drug BRAF Inhibitors for NSCLC Historic Market Size by Type (2017-2022)
    4.2 Global Targeted Drug BRAF Inhibitors for NSCLC Forecasted Market Size by Type (2023-2028)
5 Targeted Drug BRAF Inhibitors for NSCLC Breakdown Data by Application
    5.1 Global Targeted Drug BRAF Inhibitors for NSCLC Historic Market Size by Application (2017-2022)
    5.2 Global Targeted Drug BRAF Inhibitors for NSCLC Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size (2017-2028)
    6.2 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type
        6.2.1 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2017-2022)
        6.2.2 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2023-2028)
        6.2.3 North America Targeted Drug BRAF Inhibitors for NSCLC Market Share by Type (2017-2028)
    6.3 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application
        6.3.1 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2017-2022)
        6.3.2 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2023-2028)
        6.3.3 North America Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application (2017-2028)
    6.4 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country
        6.4.1 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2017-2022)
        6.4.2 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size (2017-2028)
    7.2 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type
        7.2.1 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2017-2022)
        7.2.2 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2023-2028)
        7.2.3 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Share by Type (2017-2028)
    7.3 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application
        7.3.1 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2017-2022)
        7.3.2 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2023-2028)
        7.3.3 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application (2017-2028)
    7.4 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country
        7.4.1 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2017-2022)
        7.4.2 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size (2017-2028)
    8.2 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type
        8.2.1 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Share by Type (2017-2028)
    8.3 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application
        8.3.1 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application (2017-2028)
    8.4 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Region
        8.4.1 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size (2017-2028)
    9.2 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type
        9.2.1 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2017-2022)
        9.2.2 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2023-2028)
        9.2.3 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Share by Type (2017-2028)
    9.3 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application
        9.3.1 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2017-2022)
        9.3.2 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2023-2028)
        9.3.3 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application (2017-2028)
    9.4 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country
        9.4.1 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2017-2022)
        9.4.2 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size (2017-2028)
    10.2 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type
        10.2.1 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Share by Type (2017-2028)
    10.3 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application
        10.3.1 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application (2017-2028)
    10.4 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country
        10.4.1 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 BeiGene
        11.1.1 BeiGene Company Details
        11.1.2 BeiGene Business Overview
        11.1.3 BeiGene Targeted Drug BRAF Inhibitors for NSCLC Introduction
        11.1.4 BeiGene Revenue in Targeted Drug BRAF Inhibitors for NSCLC Business (2017-2022)
        11.1.5 BeiGene Recent Developments
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Targeted Drug BRAF Inhibitors for NSCLC Introduction
        11.2.4 Novartis Revenue in Targeted Drug BRAF Inhibitors for NSCLC Business (2017-2022)
        11.2.5 Novartis Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Dabrafenib
    Table 3. Key Players of Trametinib
    Table 4. Key Players of Lifirafenib
    Table 5. Key Players of Other
    Table 6. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Region (2017-2022)
    Table 10. Global Targeted Drug BRAF Inhibitors for NSCLC Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Region (2023-2028)
    Table 12. Targeted Drug BRAF Inhibitors for NSCLC Market Trends
    Table 13. Targeted Drug BRAF Inhibitors for NSCLC Market Drivers
    Table 14. Targeted Drug BRAF Inhibitors for NSCLC Market Challenges
    Table 15. Targeted Drug BRAF Inhibitors for NSCLC Market Restraints
    Table 16. Global Targeted Drug BRAF Inhibitors for NSCLC Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Targeted Drug BRAF Inhibitors for NSCLC Revenue Share by Players (2017-2022)
    Table 18. Global Top Targeted Drug BRAF Inhibitors for NSCLC by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drug BRAF Inhibitors for NSCLC as of 2021)
    Table 19. Ranking of Global Top Targeted Drug BRAF Inhibitors for NSCLC Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Targeted Drug BRAF Inhibitors for NSCLC Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Targeted Drug BRAF Inhibitors for NSCLC Product Solution and Service
    Table 23. Date of Enter into Targeted Drug BRAF Inhibitors for NSCLC Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Targeted Drug BRAF Inhibitors for NSCLC Revenue Market Share by Type (2017-2022)
    Table 27. Global Targeted Drug BRAF Inhibitors for NSCLC Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Targeted Drug BRAF Inhibitors for NSCLC Revenue Market Share by Type (2023-2028)
    Table 29. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Targeted Drug BRAF Inhibitors for NSCLC Revenue Share by Application (2017-2022)
    Table 31. Global Targeted Drug BRAF Inhibitors for NSCLC Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Targeted Drug BRAF Inhibitors for NSCLC Revenue Share by Application (2023-2028)
    Table 33. North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2023-2028) & (US$ Million)
    Table 63. BeiGene Company Details
    Table 64. BeiGene Business Overview
    Table 65. BeiGene Targeted Drug BRAF Inhibitors for NSCLC Product
    Table 66. BeiGene Revenue in Targeted Drug BRAF Inhibitors for NSCLC Business (2017-2022) & (US$ Million)
    Table 67. BeiGene Recent Developments
    Table 68. Novartis Company Details
    Table 69. Novartis Business Overview
    Table 70. Novartis Targeted Drug BRAF Inhibitors for NSCLC Product
    Table 71. Novartis Revenue in Targeted Drug BRAF Inhibitors for NSCLC Business (2017-2022) & (US$ Million)
    Table 72. Novartis Recent Developments
    Table 73. Research Programs/Design for This Report
    Table 74. Key Data Information from Secondary Sources
    Table 75. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Type: 2021 VS 2028
    Figure 2. Dabrafenib Features
    Figure 3. Trametinib Features
    Figure 4. Lifirafenib Features
    Figure 5. Other Features
    Figure 6. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application: 2021 VS 2028
    Figure 7. Squamous Cell Carcinoma of NSCLC Case Studies
    Figure 8. Adenocarcinoma of NSCLC Case Studies
    Figure 9. Large Cell Carcinoma of NSCLC Case Studies
    Figure 10. Targeted Drug BRAF Inhibitors for NSCLC Report Years Considered
    Figure 11. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Region: 2021 VS 2028
    Figure 14. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Players in 2021
    Figure 15. Global Top Targeted Drug BRAF Inhibitors for NSCLC Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drug BRAF Inhibitors for NSCLC as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Targeted Drug BRAF Inhibitors for NSCLC Revenue in 2021
    Figure 17. North America Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Targeted Drug BRAF Inhibitors for NSCLC Market Size Market Share by Type (2017-2028)
    Figure 19. North America Targeted Drug BRAF Inhibitors for NSCLC Market Size Market Share by Application (2017-2028)
    Figure 20. North America Targeted Drug BRAF Inhibitors for NSCLC Market Size Share by Country (2017-2028)
    Figure 21. United States Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size Share by Country (2017-2028)
    Figure 27. Germany Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size Share by Region (2017-2028)
    Figure 37. China Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size Share by Country (2017-2028)
    Figure 47. Mexico Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size Share by Country (2017-2028)
    Figure 53. Turkey Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. BeiGene Revenue Growth Rate in Targeted Drug BRAF Inhibitors for NSCLC Business (2017-2022)
    Figure 57. Novartis Revenue Growth Rate in Targeted Drug BRAF Inhibitors for NSCLC Business (2017-2022)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed